Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

Current Volume 13(1) 2008 (7)

#843644

28 Mar 2008   

Anti-Fya antibodies as the cause of an unfortunate post-transplant course in renal transplant recipient

Ewa Wątorek, Maria Boratyńska [...]

Ann Transplant 2008; 13(1): 48-52 :: ID: 843644

#843644

28 Mar 2008   

Anti-Fya antibodies as the cause of an unfortunate post-transplant course in renal transplant recipient

Ewa Wątorek, Maria Boratyńska, Agnieszka Hałoń, Marian Klinger

Ann Transplant 2008; 13(1): 48-52 :: ID: 843644

571 48

#843643

28 Mar 2008   

BCNU toxicity presenting with a large pericardial and pleural effusion

Ganapathy S. Krishnan, Vijay Chaudhary [...]

Ann Transplant 2008; 13(1): 44-47 :: ID: 843643

#843643

28 Mar 2008   

BCNU toxicity presenting with a large pericardial and pleural effusion

Ganapathy S. Krishnan, Vijay Chaudhary, Anas Al-Janadi, Jeyanthi Ramanarayanan, Karl J. D’Silva

Ann Transplant 2008; 13(1): 44-47 :: ID: 843643

564 10

#843642

28 Mar 2008   

An Attempt To Assess The Influence Of Primary Disease On The Results Of Therapeutic Rehabilitation In An Early Post-Operative Period In Orthotopic Liver Transplant Recipients

Witold Rongies, Sylwia Stępniewska [...]

Ann Transplant 2008; 13(1): 40-43 :: ID: 843642

#843642

28 Mar 2008   

An Attempt To Assess The Influence Of Primary Disease On The Results Of Therapeutic Rehabilitation In An Early Post-Operative Period In Orthotopic Liver Transplant Recipients

Witold Rongies, Sylwia Stępniewska, Barbara Golińska, Mikołaj Wojtaszek, Włodzimierz Dolecki, Monika Lewandowska, Dariusz Białoszewski, Marek Krawczyk

Ann Transplant 2008; 13(1): 40-43 :: ID: 843642

346 18

#843641

28 Mar 2008   

Safety and efficacy of high dose ATG bolus administration on rewascularization in kidney graft patients – long term results

Radosław Samsel, Jacek Pliszczyński [...]

Ann Transplant 2008; 13(1): 32-39 :: ID: 843641

#843641

28 Mar 2008   

Safety and efficacy of high dose ATG bolus administration on rewascularization in kidney graft patients – long term results

Radosław Samsel, Jacek Pliszczyński, Andrzej Chmura, Grażyna Korczak, Zbigniew Włodarczyk, Tomasz Cieciura, Beata Lagiewska, Maciej Glyda, Janusz Wyzgal, Leszek Pączek, Magdalena Durlik, Wojciech Rowiński

Ann Transplant 2008; 13(1): 32-39 :: ID: 843641

383 32

#843640

28 Mar 2008   

No transmission of porcine endogenous retroviruses (PERVs) in a long-term pig to rat xenotransplantation model and no infection of immunosuppressed rats

Joachim Denner, Volker Specke [...]

Ann Transplant 2008; 13(1): 20-31 :: ID: 843640

#843640

28 Mar 2008   

No transmission of porcine endogenous retroviruses (PERVs) in a long-term pig to rat xenotransplantation model and no infection of immunosuppressed rats

Joachim Denner, Volker Specke, Alexander Karlas, Irina Chodnevskaja, Thomas Meyer, Vasiliy Moskalenko, Reinhard Kurth, Karin Ulrichs

Ann Transplant 2008; 13(1): 20-31 :: ID: 843640

541 5

#843639

28 Mar 2008   

The role of IL-6 during the late phase of liver regeneration

Maria Pachówka, Jolanta Żegarska [...]

Ann Transplant 2008; 13(1): 15-19 :: ID: 843639

#843639

28 Mar 2008   

The role of IL-6 during the late phase of liver regeneration

Maria Pachówka, Jolanta Żegarska, Rafał Ciecierski, Grażyna Korczak-Kowalska

Ann Transplant 2008; 13(1): 15-19 :: ID: 843639

551 9

#843635

28 Mar 2008   

Renal transplantation practice in Iran and the middle east: report from Iran and a review of the literature

Behzad Einollahi, Saeed Taheri

Ann Transplant 2008; 13(1): 5-14 :: ID: 843635

#843635

28 Mar 2008   

Renal transplantation practice in Iran and the middle east: report from Iran and a review of the literature

Behzad Einollahi, Saeed Taheri

Ann Transplant 2008; 13(1): 5-14 :: ID: 843635

510 7

Volume 13(1) 2008 (7) Supplement

#880210

01 Jan 2008 :   

Drug lymphocyte level: New perspective in clinical immunosuppression monitoring

A. Barbari,

Ann Transplant 2008; 13(1): 43-43 :: ID: 880210

239 0

#880210

01 Jan 2008 :   

Drug lymphocyte level: New perspective in clinical immunosuppression monitoring

A. Barbari

Ann Transplant 2008; 13(1): 43-43 :: ID: 880210

239 0

#880211

01 Jan 2008 :   

Comparing graft function for tacrolimus- and cyclosporine-treated patients. A long-term comparative study involving nephrotoxicity markers

Z. Marchewka, J. Kuźniar [...]

Ann Transplant 2008; 13(1): 43-43 :: ID: 880211

237 0

#880211

01 Jan 2008 :   

Comparing graft function for tacrolimus- and cyclosporine-treated patients. A long-term comparative study involving nephrotoxicity markers

Z. Marchewka, J. Kuźniar, K. Falkiewicz, B. Szymańska, M. Zynek-Litwin, D. Patrzałek, A. Długosz, M. Klinger

Ann Transplant 2008; 13(1): 43-43 :: ID: 880211

237 0

#880208

01 Jan 2008 :   

Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration

L. R. Chiarelli, M. Molinaro [...]

Ann Transplant 2008; 13(1): 42-42 :: ID: 880208

257 0

#880208

01 Jan 2008 :   

Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration

L. R. Chiarelli, M. Molinaro, C. Libetta, C. Tinelli, L. Cosmai, G. Valentini, A. Dal Canton, M. Regazzi

Ann Transplant 2008; 13(1): 42-42 :: ID: 880208

257 0

#880209

01 Jan 2008 :   

Biomarkers assays for T-lymphocyte activation and proliferation applied in a multicenter clinical trial of AEB071 in renal transplantation

J. M. Kovarik, K. Budde [...]

Ann Transplant 2008; 13(1): 42-42 :: ID: 880209

260 0

#880209

01 Jan 2008 :   

Biomarkers assays for T-lymphocyte activation and proliferation applied in a multicenter clinical trial of AEB071 in renal transplantation

J. M. Kovarik, K. Budde, J. Steiger, J. M. Grinyo, F. Straube, A. Groenewegen, A. Vitalit, J. Geissler, J. Klupp, M. J. Barten

Ann Transplant 2008; 13(1): 42-42 :: ID: 880209

260 0

#880206

01 Jan 2008 :   

Association between pharmacodynamic parameters and clinical events under therapy with EC-MPS in the early phase after kidney transplantation (KTx)

E. Wieland, M. Shipkova [...]

Ann Transplant 2008; 13(1): 41-41 :: ID: 880206

299 0

#880206

01 Jan 2008 :   

Association between pharmacodynamic parameters and clinical events under therapy with EC-MPS in the early phase after kidney transplantation (KTx)

E. Wieland, M. Shipkova, Y. Martius, G. Hasche, C. Klett, R. Bolley, C. Olbricht

Ann Transplant 2008; 13(1): 41-41 :: ID: 880206

299 0

#880207

01 Jan 2008 :   

IMPDH activity on day 6 after kidney transplantation is significantly related to the risk of acute rejection in MMF treated patients

F. Sombogaard, R.A.A. Mathot [...]

Ann Transplant 2008; 13(1): 41-42 :: ID: 880207

238 0

#880207

01 Jan 2008 :   

IMPDH activity on day 6 after kidney transplantation is significantly related to the risk of acute rejection in MMF treated patients

F. Sombogaard, R.A.A. Mathot, P. Glander, W. Weimar, T. van Gelder

Ann Transplant 2008; 13(1): 41-42 :: ID: 880207

238 0

#880203

01 Jan 2008 :   

Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?

H. Tesfaye, R. Prusa [...]

Ann Transplant 2008; 13(1): 40-40 :: ID: 880203

248 0

#880203

01 Jan 2008 :   

Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?

H. Tesfaye, R. Prusa, B. Jedlickova, J. Segethova

Ann Transplant 2008; 13(1): 40-40 :: ID: 880203

248 0

#880204

01 Jan 2008 :   

Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufficiency

M. Chrzanowska, J. Kamińska [...]

Ann Transplant 2008; 13(1): 40-40 :: ID: 880204

229 0

#880204

01 Jan 2008 :   

Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufficiency

M. Chrzanowska, J. Kamińska, M. Głyda, N. Wachowiak

Ann Transplant 2008; 13(1): 40-40 :: ID: 880204

229 0

#880205

01 Jan 2008 :   

Tacrolimus – biotechnological prospects for a generic product

W. Gajzlerska, J. Turło [...]

Ann Transplant 2008; 13(1): 40-41 :: ID: 880205

255 0

#880205

01 Jan 2008 :   

Tacrolimus – biotechnological prospects for a generic product

W. Gajzlerska, J. Turło, B. Gutkowska, F. Herold

Ann Transplant 2008; 13(1): 40-41 :: ID: 880205

255 0

#880201

01 Jan 2008 :   

Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation tool

J.E. Wallin, L. E. Friberg [...]

Ann Transplant 2008; 13(1): 39-39 :: ID: 880201

246 0

#880201

01 Jan 2008 :   

Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation tool

J.E. Wallin, L. E. Friberg, A. Fasth, C. E. Staatz

Ann Transplant 2008; 13(1): 39-39 :: ID: 880201

246 0

#880202

01 Jan 2008 :   

Therapeutic Drug Monitoring of tacrolimus in renal transplant patients

B. Solnica, K. Słowińska-Solnica [...]

Ann Transplant 2008; 13(1): 39-40 :: ID: 880202

254 0

#880202

01 Jan 2008 :   

Therapeutic Drug Monitoring of tacrolimus in renal transplant patients

B. Solnica, K. Słowińska-Solnica, E. Ignacak, J. W. Naskalski

Ann Transplant 2008; 13(1): 39-40 :: ID: 880202

254 0

#880198

01 Jan 2008 :   

Evaluating co-medication and matrix interference influence on ion yields: A key step in therapeutic drug monitoring HPLC-MS/MS assay validation

C. Seger, M. Bock [...]

Ann Transplant 2008; 13(1): 38-38 :: ID: 880198

255 0

#880198

01 Jan 2008 :   

Evaluating co-medication and matrix interference influence on ion yields: A key step in therapeutic drug monitoring HPLC-MS/MS assay validation

C. Seger, M. Bock, K. Tentschert, A. Griesmacher

Ann Transplant 2008; 13(1): 38-38 :: ID: 880198

255 0

#880199

01 Jan 2008 :   

Comparison of tacrolimus levels obtained with twice-daily administration formulation (Prograf®) and with once-daily formulation (Advagraf®)

M. T. Rabuñal Álvarez, E. Fernández Gabriel [...]

Ann Transplant 2008; 13(1): 38-38 :: ID: 880199

213 0

#880199

01 Jan 2008 :   

Comparison of tacrolimus levels obtained with twice-daily administration formulation (Prograf®) and with once-daily formulation (Advagraf®)

M. T. Rabuñal Álvarez, E. Fernández Gabriel, M. Outeda Macías, I. Martín Herranz

Ann Transplant 2008; 13(1): 38-38 :: ID: 880199

213 0

#880200

01 Jan 2008 :   

Conversion from tacrolimus twice a day formulation to once-daily tacrolimus in kidney transplant recipients

D. Kamińska, M. Kuriata-Kordek [...]

Ann Transplant 2008; 13(1): 38-39 :: ID: 880200

239 0

#880200

01 Jan 2008 :   

Conversion from tacrolimus twice a day formulation to once-daily tacrolimus in kidney transplant recipients

D. Kamińska, M. Kuriata-Kordek, M. Boratyńska, K. Falkiewicz, M. Klinger

Ann Transplant 2008; 13(1): 38-39 :: ID: 880200

239 0

#880196

01 Jan 2008 :   

Siemens Healthcare Diagnostics immunosuppressive drug monitoring solutions

T. Wei, N. Morjana [...]

Ann Transplant 2008; 13(1): 37-37 :: ID: 880196

301 0

#880196

01 Jan 2008 :   

Siemens Healthcare Diagnostics immunosuppressive drug monitoring solutions

T. Wei, N. Morjana, S. Goss, L. Bantum, Y. Yue, R. Janzen, G. Siefring

Ann Transplant 2008; 13(1): 37-37 :: ID: 880196

301 0

#880197

01 Jan 2008 :   

Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays

P. Wallemacq, J. S. Goffinet [...]

Ann Transplant 2008; 13(1): 37-38 :: ID: 880197

272 0

#880197

01 Jan 2008 :   

Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays

P. Wallemacq, J. S. Goffinet, H. Ait-Youcef

Ann Transplant 2008; 13(1): 37-38 :: ID: 880197

272 0

#880193

01 Jan 2008 :   

Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles

N. W. Brown, P. Arampatzis [...]

Ann Transplant 2008; 13(1): 36-36 :: ID: 880193

292 0

#880193

01 Jan 2008 :   

Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles

N. W. Brown, P. Arampatzis, C. E. Gonde, M. Pires, J. Tracey, M. Tredger

Ann Transplant 2008; 13(1): 36-36 :: ID: 880193

292 0

#880195

01 Jan 2008 :   

Evaluation of a commercially available whole blood calibrator and control kit for the analysis of cyclosporin A, everolimus, sirolimus and tacrolimus using LC/MS/MS technology

A. M. Taylor, T. N. Gamble [...]

Ann Transplant 2008; 13(1): 36-37 :: ID: 880195

225 0

#880195

01 Jan 2008 :   

Evaluation of a commercially available whole blood calibrator and control kit for the analysis of cyclosporin A, everolimus, sirolimus and tacrolimus using LC/MS/MS technology

A. M. Taylor, T. N. Gamble, D. Blake, T. Drury, M. Ehrdhard

Ann Transplant 2008; 13(1): 36-37 :: ID: 880195

225 0

#880192

29 Sep 2008 :   

The role of genetics and pharmacogenetic monitoring in transplantation

M. Masri,

Ann Transplant 2008; 13(1): 35-35 :: ID: 880192

238 0

#880192

29 Sep 2008 :   

The role of genetics and pharmacogenetic monitoring in transplantation

M. Masri

Ann Transplant 2008; 13(1): 35-35 :: ID: 880192

238 0

#880189

01 Jan 2008 :   

In vivo hepatic CYP3A4 activity is significantly higher in tacrolimus treated vs cyclosporine treated renal transplant recipients

H. de Jonge, M. Naesens [...]

Ann Transplant 2008; 13(1): 34-34 :: ID: 880189

246 0

#880189

01 Jan 2008 :   

In vivo hepatic CYP3A4 activity is significantly higher in tacrolimus treated vs cyclosporine treated renal transplant recipients

H. de Jonge, M. Naesens, K. Verbeke, Y. Vanrenterghem, D. R. Kuypers

Ann Transplant 2008; 13(1): 34-34 :: ID: 880189

246 0

#880190

01 Jan 2008 :   

In vitro investigation of MRP 2 in the cyclosporine A – pravastatin interplay

R.l Kato, M. Nishide [...]

Ann Transplant 2008; 13(1): 34-34 :: ID: 880190

246 0

#880190

01 Jan 2008 :   

In vitro investigation of MRP 2 in the cyclosporine A – pravastatin interplay

R.l Kato, M. Nishide, C. Kodzu, Y. Ijiri, K. Tanaka

Ann Transplant 2008; 13(1): 34-34 :: ID: 880190

246 0

#880191

01 Jan 2008 :   

The CYP3A5*1/*3 single nucleotide polymorphism (SNP) determines the extent of drug interaction between tacrolimus and fluconazole in renal transplant recipients

H. de Jonge, M. Naesens [...]

Ann Transplant 2008; 13(1): 34-35 :: ID: 880191

255 0

#880191

01 Jan 2008 :   

The CYP3A5*1/*3 single nucleotide polymorphism (SNP) determines the extent of drug interaction between tacrolimus and fluconazole in renal transplant recipients

H. de Jonge, M. Naesens, Y. Vanrenterghem, D. R. Kuypers

Ann Transplant 2008; 13(1): 34-35 :: ID: 880191

255 0

#880187

01 Jan 2008 :   

The pregnane X receptor C-25385t single nucleotide polymorphism (SNP) does not affect tacrolimus pharmacokinetics in a large cohort of renal transplant recipients

H. de Jonge, M. Naesens [...]

Ann Transplant 2008; 13(1): 33-33 :: ID: 880187

300 0

#880187

01 Jan 2008 :   

The pregnane X receptor C-25385t single nucleotide polymorphism (SNP) does not affect tacrolimus pharmacokinetics in a large cohort of renal transplant recipients

H. de Jonge, M. Naesens, Y. Vanrenterghem, D. R. Kuypers

Ann Transplant 2008; 13(1): 33-33 :: ID: 880187

300 0

#880188

01 Jan 2008 :   

The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in caucasian liver transplant patients

A. Provenzani, M. Notarbartolo [...]

Ann Transplant 2008; 13(1): 33-33 :: ID: 880188

238 0

#880188

01 Jan 2008 :   

The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in caucasian liver transplant patients

A. Provenzani, M. Notarbartolo, F. Biondi, M. Labbozzetta, P. Poma, G. Vizzini, U. Palazzo, P. Polidori, F. Triolo, B. Gridelli, N. D'Alessandro

Ann Transplant 2008; 13(1): 33-33 :: ID: 880188

238 0

#880186

01 Jan 2008 :   

Modified release formulation in immunotherapy – the tacrolimus case

N. Undre,

Ann Transplant 2008; 13(1): 32-32 :: ID: 880186

256 0

#880186

01 Jan 2008 :   

Modified release formulation in immunotherapy – the tacrolimus case

N. Undre

Ann Transplant 2008; 13(1): 32-32 :: ID: 880186

256 0

#880185

01 Jan 2008 :   

Generic substitution of immunosuppressive drugs – requirements for an equivalent product

A. Johnston, D. W. Holt

Ann Transplant 2008; 13(1): 31-31 :: ID: 880185

231 0

#880185

01 Jan 2008 :   

Generic substitution of immunosuppressive drugs – requirements for an equivalent product

A. Johnston, D. W. Holt

Ann Transplant 2008; 13(1): 31-31 :: ID: 880185

231 0

#880184

01 Jan 2008 :   

Generic products – requirements for drug registration

P. K. Kunicki,

Ann Transplant 2008; 13(1): 30-30 :: ID: 880184

216 0

#880184

01 Jan 2008 :   

Generic products – requirements for drug registration

P. K. Kunicki

Ann Transplant 2008; 13(1): 30-30 :: ID: 880184

216 0

#880183

01 Jan 2008 :   

Therapeutic drug monitoring of immunosuppressive drugs – future perspectives

P. Wallemacq,

Ann Transplant 2008; 13(1): 29-29 :: ID: 880183

228 0

#880183

01 Jan 2008 :   

Therapeutic drug monitoring of immunosuppressive drugs – future perspectives

P. Wallemacq

Ann Transplant 2008; 13(1): 29-29 :: ID: 880183

228 0

#880182

01 Jan 2008 :   

Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring

D. R. Kuypers,

Ann Transplant 2008; 13(1): 28-28 :: ID: 880182

245 0

#880182

01 Jan 2008 :   

Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring

D. R. Kuypers

Ann Transplant 2008; 13(1): 28-28 :: ID: 880182

245 0

#880180

01 Jan 2008 :   

Therapeutic drug monitoring of sirolimus and everolimus

E.M. Billaud,

Ann Transplant 2008; 13(1): 26-26 :: ID: 880180

226 0

#880180

01 Jan 2008 :   

Therapeutic drug monitoring of sirolimus and everolimus

E.M. Billaud

Ann Transplant 2008; 13(1): 26-26 :: ID: 880180

226 0

#880179

01 Jan 2008 :   

Therapeutic drug monitoring of tacrolimus

P. Wallemacq,

Ann Transplant 2008; 13(1): 25-25 :: ID: 880179

229 0

#880179

01 Jan 2008 :   

Therapeutic drug monitoring of tacrolimus

P. Wallemacq

Ann Transplant 2008; 13(1): 25-25 :: ID: 880179

229 0

#880178

01 Jan 2008 :   

Therapeutic drug monitoring of ciclosporin

A. Johnston, D. W. Holt

Ann Transplant 2008; 13(1): 24-24 :: ID: 880178

247 0

#880178

01 Jan 2008 :   

Therapeutic drug monitoring of ciclosporin

A. Johnston, D. W. Holt

Ann Transplant 2008; 13(1): 24-24 :: ID: 880178

247 0

#880177

01 Jan 2008 :   

Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the curve in patients receiving concomitant sirolimus or cyclosporine

L. M. Shaw, M. Figurski, M. D. Pescovitz

Ann Transplant 2008; 13(1): 23-23 :: ID: 880177

229 0

#880176

01 Jan 2008 :   

Clinical application of population pharmacokinetic methods developed for immunosuppressive drugs

P. Marquet,

Ann Transplant 2008; 13(1): 22-22 :: ID: 880176

282 0

#880176

01 Jan 2008 :   

Clinical application of population pharmacokinetic methods developed for immunosuppressive drugs

P. Marquet

Ann Transplant 2008; 13(1): 22-22 :: ID: 880176

282 0

#880175

01 Jan 2008 :   

What can we learn from proficiency testing of immunosuppressive drug assays?

D. W. Holt, A. Johnston

Ann Transplant 2008; 13(1): 21-21 :: ID: 880175

215 0

#880175

01 Jan 2008 :   

What can we learn from proficiency testing of immunosuppressive drug assays?

D. W. Holt, A. Johnston

Ann Transplant 2008; 13(1): 21-21 :: ID: 880175

215 0

#880174

01 Jan 2008 :   

Immunoassays for immunosuppressive drugs – benefi ts and risks

W. Steimer,

Ann Transplant 2008; 13(1): 20-20 :: ID: 880174

252 0

#880174

01 Jan 2008 :   

Immunoassays for immunosuppressive drugs – benefi ts and risks

W. Steimer

Ann Transplant 2008; 13(1): 20-20 :: ID: 880174

252 0

#880173

01 Jan 2008 :   

Review of the newest HPLC-MS/MS methods for determination of immunosuppressive drugs in clinical practice

M. Korecka,

Ann Transplant 2008; 13(1): 19-19 :: ID: 880173

201 0

#880173

01 Jan 2008 :   

Review of the newest HPLC-MS/MS methods for determination of immunosuppressive drugs in clinical practice

M. Korecka

Ann Transplant 2008; 13(1): 19-19 :: ID: 880173

201 0

#880171

01 Jan 2008 :   

Biomarkers - as an adjunct to immunosuppressive drug monitoring

M. Oellerich,

Ann Transplant 2008; 13(1): 17-17 :: ID: 880171

300 0

#880171

01 Jan 2008 :   

Biomarkers - as an adjunct to immunosuppressive drug monitoring

M. Oellerich

Ann Transplant 2008; 13(1): 17-17 :: ID: 880171

300 0

#880170

01 Jan 2008 :   

PK/PD modelling of immunosuppressive agents

E. Wyska,

Ann Transplant 2008; 13(1): 16-16 :: ID: 880170

300 0

#880170

01 Jan 2008 :   

PK/PD modelling of immunosuppressive agents

E. Wyska

Ann Transplant 2008; 13(1): 16-16 :: ID: 880170

300 0

#880169

01 Jan 2008 :   

Drug transporters for immunosuppressive agents

I.A.M. MacPhee,

Ann Transplant 2008; 13(1): 15-15 :: ID: 880169

190 0

#880169

01 Jan 2008 :   

Drug transporters for immunosuppressive agents

I.A.M. MacPhee

Ann Transplant 2008; 13(1): 15-15 :: ID: 880169

190 0

#880168

01 Jan 2008 :   

Pharmacogenetics in immunotherapy: present knowledge and future perspectives

D. A. Hesselink,

Ann Transplant 2008; 13(1): 13-14 :: ID: 880168

316 0

#880168

01 Jan 2008 :   

Pharmacogenetics in immunotherapy: present knowledge and future perspectives

D. A. Hesselink

Ann Transplant 2008; 13(1): 13-14 :: ID: 880168

316 0

#880167

01 Jan 2008 :   

Pharmacokinetic principles of immunosuppressive-drugs

K. Budde, P. Glander

Ann Transplant 2008; 13(1): 12-12 :: ID: 880167

257 0

#880167

01 Jan 2008 :   

Pharmacokinetic principles of immunosuppressive-drugs

K. Budde, P. Glander

Ann Transplant 2008; 13(1): 12-12 :: ID: 880167

257 0

#880166

01 Jan 2008 :   

Clinical immunosuppression – current status

M. Klinger,

Ann Transplant 2008; 13(1): 11-11 :: ID: 880166

283 0

#880166

01 Jan 2008 :   

Clinical immunosuppression – current status

M. Klinger

Ann Transplant 2008; 13(1): 11-11 :: ID: 880166

283 0

#880165

01 Jan 2008 :   

New insight of immunosuppressive drugs related nephrotoxicity

E. Thervet,

Ann Transplant 2008; 13(1): 10-10 :: ID: 880165

269 0

#880165

01 Jan 2008 :   

New insight of immunosuppressive drugs related nephrotoxicity

E. Thervet

Ann Transplant 2008; 13(1): 10-10 :: ID: 880165

269 0

#880164

01 Jan 2008 :   

Organ transplantation in Poland

M. Durlik,

Ann Transplant 2008; 13(1): 9-9 :: ID: 880164

287 0

#880164

01 Jan 2008 :   

Organ transplantation in Poland

M. Durlik

Ann Transplant 2008; 13(1): 9-9 :: ID: 880164

287 0

In Press

10 Nov 2023 : Original article  

Effects of Preservation of Donor Liver Gastroduodenal Artery on Post-Transplant Biliary Complications in 18...

Ann Transplant In Press; DOI:  

07 Nov 2023 : Original article  

Allogeneic Hematopoietic Stem Cell Transplantation Can Improve Prognosis of Extramedullary Infiltration Pos...

Ann Transplant In Press; DOI:  

06 Nov 2023 : Original article  

Clinical Outcomes of Administration of Rituximab for Desensitization in Liver Transplant Patients with Pref...

Ann Transplant In Press; DOI:  

06 Nov 2023 : Original article  

Short-Term Monitoring of Graft Regeneration in Partial Liver Transplantation Recipients

Ann Transplant In Press; DOI:  

Most Viewed Current Articles

24 Aug 2021 : Review article  

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

26 Jan 2022 : Review article  

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models

DOI :10.12659/AOT.934924

Ann Transplant 2022; 27:e934924

29 Dec 2021 : Original article  

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358